RXO (NYSE:RXO – Get Free Report) had its price objective cut by research analysts at Morgan Stanley from $27.00 to $25.00 in a report issued on Thursday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective points to a potential upside of 20.22% from the company’s current price.
RXO has been the topic of a number of other research reports. The Goldman Sachs Group restated a “neutral” rating and set a $29.00 target price on shares of RXO in a research report on Monday, November 18th. Susquehanna cut their price target on shares of RXO from $16.00 to $12.00 and set a “negative” rating on the stock in a research note on Tuesday, November 12th. Citigroup downgraded shares of RXO from a “buy” rating to a “neutral” rating and set a $33.00 target price on the stock. in a research note on Tuesday, November 12th. Barclays cut their target price on shares of RXO from $32.00 to $30.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Finally, Stifel Nicolaus raised their target price on shares of RXO from $26.00 to $27.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $26.71.
Get Our Latest Research Report on RXO
RXO Price Performance
RXO (NYSE:RXO – Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.06. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. As a group, equities analysts anticipate that RXO will post 0.12 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of RXO. Oregon Public Employees Retirement Fund lifted its position in RXO by 1.5% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 32,863 shares of the company’s stock valued at $783,000 after purchasing an additional 500 shares during the last quarter. GAMMA Investing LLC raised its position in shares of RXO by 40.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock worth $50,000 after buying an additional 510 shares in the last quarter. Blue Trust Inc. raised its position in shares of RXO by 79.7% during the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company’s stock worth $27,000 after buying an additional 510 shares in the last quarter. Mutual of America Capital Management LLC raised its position in shares of RXO by 2.7% during the 4th quarter. Mutual of America Capital Management LLC now owns 21,190 shares of the company’s stock worth $505,000 after buying an additional 551 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. raised its position in shares of RXO by 68.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock worth $39,000 after buying an additional 570 shares in the last quarter. 92.73% of the stock is owned by institutional investors and hedge funds.
RXO Company Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Recommended Stories
- Five stocks we like better than RXO
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.